Therapeutic Products Bill Submission!

Myeloma New Zealand has made a submission on the Therapeutic Products Bill, as it has implications for Myeloma Patients. The Chair of the Health Committee has called for public submissions on the Therapeutic Products Bill. Therapeutic Products are medicines, medical devices, natural health products, and pharmaceutical ingredients. The bill seeks to provide for the regulation of therapeutic products in a way that is comprehensive and balances the risks and benefits of the products.

At present, the Medicines Act 1981 is the main legislation for enabling access to safe medicines and medical devices. Natural health products are regulated by the Dietary Supplements Regulations 1985 under the Food Act 2014. The bill would repeal most provisions of the Medicines Act, except those relating to pharmacy ownership, and revoke the regulations made under the Act. It would also revoke the Dietary Supplements Regulations. 

Changes that the bill proposes include:

  • ​requiring therapeutic products to receive a market authorisation before they could be imported into, exported from, or supplied in New Zealand
  • providing for the regulation of a range of controlled activities
  • establishing a Therapeutics Products Regulator
The closing date for submissions is 11.59pm Sunday, 05 March 2023.Read more about the bill here: Therapeutic-products-bill

Latest News

In Focus: From the lab to the clinic in New Zealand’s first CAR T-cell therapy clinical trial

Nathaniel works in the research team, where the CAR T-cells are designed, and supports both the GMP team, where the...
Continue Reading

FRAIL-M Study for Newly-Diagnosed Multiple Myeloma

The Australasian Myeloma Research Consortium (AMaRC) in collaboration with theAustralasian Leukaemia & Lymphoma Group (ALLG) and the Myeloma and Related...
Continue Reading

Consensus statement on the treatment of transplant eligible patients with newly diagnosed multiple myeloma in New Zealand

The New Zealand Myeloma Interest Group is comprised of representative haematologists from District Health Boards around the country with a...
Continue Reading

Multiple Myeloma Summit 2022

Myeloma experts convened in person and online for the 2022 Multiple Myeloma Queenstown Summit, hosted by Myeloma New Zealand. This...
Continue Reading

Multiple Myeloma NZ campaigns for Pharmac to fund medicine

Myeloma New Zealand has started a campaign to press Pharmac into funding a treatment that has been standard-of-care throughout the...
Continue Reading

Burden of Multiple Myeloma

Treatment resources

Clinical trials

Download the ClinTrial Refer App

Q & A – Your Questions Answered

Each month we’ll select questions to answer about multiple myeloma. 

Submit your question by clicking this link 

You may also send an email to: 

Questions selected and answered will be available on our Q&A page here. 

An email address is needed for administration purposes only and will remain confidential. Questions will be answered in the context of multiple myeloma in New Zealand.

Subscribe to our Newsletter

Join our database to receive newsletters, updates, and seminar invitations.